Safety Assessment

Comprehensive, GLP-compliant services to support discovery programs, IND and NDA filings with FDA, EMA and CFDA

Pharmaron’s experienced team evaluates the safety of new drug candidates from general toxicology, safety pharmacology, genetic toxicology, DART to immunotoxicity and immunogenicity in support of our partner’s IND and NDA submissions worldwide at our FDA, OECD and CFDA GLP-compliant and AAALAC-accredited safety assessment facility.